# Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure

> **NCT05740293** · — · COMPLETED · sponsor: **Carl Zeiss Meditec, Inc.** · enrollment: 186 (actual)

## Conditions studied

- Myopia
- Astigmatism

## Interventions

- **PROCEDURE:** VisuMax SMILE procedure for the reduction or elimination of myopia with astigmatism

## Key facts

- **NCT ID:** NCT05740293
- **Lead sponsor:** Carl Zeiss Meditec, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-05
- **Primary completion:** 2024-09-01
- **Final completion:** 2025-08-25
- **Target enrollment:** 186 (ACTUAL)
- **Last updated:** 2025-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05740293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05740293, "Post-approval Study of New Enrolment Patients Undergoing Bilateral Treatment With the VisuMax SMILE Procedure". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05740293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*